| 7.12 Data as of May 20 |  -0.03 / -0.42%Today’s Change | 6.65 Today|||52-Week Range 10.63 | -6.81% Year-to-Date |
| Previous close | 7.15 |
| Today’s open | 7.18 |
| Day’s range | -- - -- |
| Volume | 38,036 |
| Average volume (3 months) | 69,594 |
| Market cap | $189.6M |
| Dividend yield | -- |
| Earnings growth (last year) | -261.47% |
| Earnings growth (this year) | +68.45% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.98 |
| Today’s change | Today’s % change | |
|---|---|---|
| ACSTAcasti Pharma Inc | +0.01 | +0.38% |
| SUPNSupernus Pharmaceuti... | +0.26 | +4.33% |
| CTIXCellceutix Corp | +0.03 | +1.49% |
| VNDAVanda Pharmaceutical... | +0.36 | +5.47% |
| Next reporting date | September 3, 2013 |
| EPS forecast (this quarter) | -$0.56 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$62.5M |
| Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chief Executive Officer & Director Paul R. Edick |
Co-President & Independent Director Dov A. Goldstein, MD, MBA |
Corporate headquarters Morristown, New Jersey |
.
